Citigroup’s West Pharmaceutical WST Stock Holding History

Citigroup’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,500	Closed	-$1.38M	–	7870
2019 Q1	$1.38M	Buy	+12,500	New	+$1.3M	﹤0.01%	3048

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Citigroup's WST Position: Q2 2026 in Review

Citigroup increased its West Pharmaceutical (WST) stake by 34% in Q2 2026, buying an estimated $14.8M and bringing the position to 190,778 shares worth $68.5M. The position accounts for 0.02% of the portfolio, ranked #609.

Citigroup first reported a position in WST in Q2 2013 and has held it in 53 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Citigroup held 190,778 shares of West Pharmaceutical worth $68.5M as of Q2 2026.
Citigroup bought 48,344 West Pharmaceutical shares in Q2 2026, an estimated $14.8M.
West Pharmaceutical made up 0.02% of Citigroup's portfolio in Q2 2026, its #609 holding.
Citigroup first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.